Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain
Phase of Trial: Phase II
Latest Information Update: 29 Apr 2019
Price : $35 *
At a glance
- Drugs Capsaicin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms CAPSONCO
- 25 Apr 2019 Planned End Date changed from 1 Oct 2020 to 30 Sep 2020.
- 25 Apr 2019 Planned primary completion date changed from 1 Oct 2020 to 30 Sep 2019.
- 10 Nov 2017 Status changed from not yet recruiting to recruiting.